Kazuki Fukui

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine‐Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction

Shingo Kato, Naka Saito, Hidekuni Kirigaya et al. · Journal of the American Heart Association · 2016 · 138 citations · Full text

Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD

Shingo Kato, Naka Saito, Tatsuya Nakachi et al. · Journal of the American College of Cardiology · 2017 · 83 citations

Cardiovascular Disease, Myocardial Infarction, Coronary Artery Disease +9

Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction

Shingo Kato, Naka Saito, Hidekuni Kirigaya et al. · International Journal of Cardiology · 2015 · 71 citations

Heart Failure, Cardiovascular Disease, Preserved Ejection Fraction +7

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki et al. · Circulation · 2022 · 56 citations · Full text